Nicholas Keen - Sep 15, 2021 Form 4 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Role: Chief Scientific Officer
Signature: /s/ Lee Kalowski, Attorney-in-Fact
Stock symbol: BCYC
Transactions as of: Sep 15, 2021
Transactions value $: -$222,995
Form type: 4
Date filed: 9/17/2021, 04:47 PM
Previous filing: Sep 3, 2021
Next filing: Oct 5, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCYC	Ordinary Shares	Sale	-$135K	-3K	-36.05%	$45.00	5.32K	Sep 15, 2021	Direct	F1
transaction	BCYC	Ordinary Shares	Sale	-$88K	-1.96K	-36.74%	$45.01	3.37K	Sep 16, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were sold pursuant to a Rule 10b5-1 trading plan.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.105 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Shares were sold pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.105 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.